Catalyst Event
Johnson & Johnson (JNJ) · Other
From Akros SCHK HK-U.S. Tech 100 Index (ASHUSTC)
4/27/2026, 12:00:00 AM
On April 27, 2026, the FDA granted Priority Review for IMAAVY (nipocalimab) for the treatment of warm autoimmune hemolytic anemia (wAIHA), a rare blood disorder.
Korean Translation
2026년 4월 27일, 희귀 혈액 질환인 온난 자가면역 용혈성 빈혈(wAIHA) 치료를 위한 IMAAVY(니포칼리맙)가 FDA로부터 우선 심사 대상으로 지정됨.
Related Recent Events
Alphabet Inc (GOOGL) · Other
Ex-dividend date (2026-06-08) for a quarterly cash dividend of $0.22 per share, representing a 5% increase from the prior dividend. The dividend was declared on April 27, 2026 and is payable on June 15, 2026. A 1-2% price impact is estimated as dividend increases are generally viewed positively by the market, scheduled.
6/8/2026, 12:00:00 AM
Sunny Optical Technology Group Co Ltd (2382) · Other
Ex-dividend date on 2026-06-05 for the proposed final dividend of HKD 1.206 per share for the 2025 fiscal year. This standard corporate action is estimated to have a >1% price impact, scheduled.
6/5/2026, 12:00:00 AM
Broadcom Inc (AVGO) · Earnings Release
Q2 2026 earnings release scheduled. Medium importance justified by anticipation of key financial performance data.
6/4/2026, 12:00:00 AM
JL mag Rare-Earth Co Ltd (6680) · Other
Ex-dividend date for the 2025 final dividend of RMB 2.2 per 10 shares on June 3, 2026. Payment is scheduled for June 26, 2026, scheduled.
6/3/2026, 12:00:00 AM
Time Interconnect Technology Ltd (1729) · Other
Annual General Meeting for 2026-05-29 scheduled.
5/29/2026, 12:00:00 AM
Kuaishou Technology (1024) · Earnings Release
Kuaishou Technology is expected to announce its first quarter 2026 financial results on May 27, 2026. Analysts forecast revenue and adjusted profit to be in line with market consensus, and the event is expected to cause over 10% price volatility expected.
5/27/2026, 12:00:00 AM